PD-L1 Crosslinking as a New Strategy of 4-1BB Agonism Immunotherapy

  1. Shu, F.
  2. Punekar, S.R.
  3. Velcheti, V.
  4. Sanmamed, M.F.
  5. Wang, J.
Revue:
Clinical Cancer Research

ISSN: 1557-3265,  1078-0432

Année de publication: 2022

Volumen: 28

Número: 15

Pages: 3182-3184

Type: Article

DOI: 10.1158/1078-0432.CCR-22-0541 GOOGLE SCHOLAR

Objectifs de Développement Durable

La source de données: Scopus